ArticleNature communications2021

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.

Katsutoshi Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.